BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3291528)

  • 1. Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreas.
    Sandberg E; Ahrén B; Tendler D; Efendic S
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):545-51. PubMed ID: 3291528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
    Ahrén B; Hedner P; Lundquist I
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of galanin on islet cell secretory responses to VIP, GIP, 8-CCK, and glucagon by the perfused rat pancreas.
    Miralles P; Peiró E; Silvestre RA; Villanueva ML; Marco J
    Metabolism; 1988 Aug; 37(8):766-70. PubMed ID: 2457142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP(1-39).
    Sandberg E; Ahrén B; Tendler D; Carlquist M; Efendić S
    Acta Physiol Scand; 1986 Jul; 127(3):323-6. PubMed ID: 3529825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas.
    Peiró E; Miralles P; Silvestre RA; Villanueva ML; Marco J
    Metabolism; 1989 Jul; 38(7):679-82. PubMed ID: 2661967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cholecystokinin, secretin, and gastric inhibitory polypeptide on insulin release from the isolated perfused rat pancreas.
    Pederson RA; Brown JC
    Can J Physiol Pharmacol; 1979 Nov; 57(11):1233-7. PubMed ID: 519526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Efendić S
    Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets.
    Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD
    J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCK-1 and CCK-2 receptor agonism do not stimulate GLP-1 and neurotensin secretion in the isolated perfused rat small intestine or GLP-1 and PYY secretion in the rat colon.
    Modvig IM; Christiansen CB; Rehfeld JF; Holst JJ; Veedfald S
    Physiol Rep; 2020 Jan; 8(2):e14352. PubMed ID: 31984675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
    Szecówka J; Sandberg E; Efendić S
    Diabetologia; 1980 Aug; 19(2):137-42. PubMed ID: 6106616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GIP potentiates CCK stimulated pancreatic enzyme secretion: correlation of anatomical structures with the effects of GIP and CCK on amylase secretion.
    Mueller MK; Scheck T; Dreesmann V; Miodonski A; Goebell H
    Pancreas; 1987; 2(1):106-13. PubMed ID: 2437570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic impact of cholecystokinin and gastric inhibitory polypeptide on the regulation of insulin secretion.
    Zawalich WS
    Metabolism; 1988 Aug; 37(8):778-81. PubMed ID: 2841557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
    Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
    Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.
    Ahrén B; Hedner P; Lundquist I
    Acta Pharmacol Toxicol (Copenh); 1986 Feb; 58(2):115-20. PubMed ID: 3518338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat.
    Szecówka J; Grill V; Sandberg E; Efendić S
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):416-21. PubMed ID: 6122321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.
    Pederson RA; Brown JC
    Endocrinology; 1978 Aug; 103(2):610-5. PubMed ID: 744105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
    Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
    Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural purified porcine gastric inhibitory polypeptide (GIP) stimulates exocrine pancreas secretion due to contamination with a cholecystokinin-like substance.
    Mueller MK; Demol P; Goebell H; Fladrich G; Brown JC
    Regul Pept; 1983 Mar; 5(4):307-15. PubMed ID: 6190197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.